Favorite  |  Set Home
Products > Others > > INCB024360
Product name : INCB024360
Item : CR1859
Price : 200mg, $845; 500mg, $1485
contact : Send inquiry to: info@acesobio.com
Additional Information :  We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
CAS : 914471-09-3
 Enlarge Image                   Back
←[Previous Product]              [Next Product]→


Details:
 Chemical Information
M.Wt 271.64 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C9H7ClFN5O2
CAS No 914471-09-3
Solubility

25°C: DMSO



Biological Activity of INCB024360

 

Description:
IC50 Value: 10nM [1]
INCB024360 is a potent IDO1 inhibitor with desirable pharmaceutical properties, which is poised to start clinical trials in cancer patients.
in vitro: In cellular assays,INCB024360 selectively inhibits human IDO1 with IC(50) values of approximately 10nM, demonstrating little activity against other related enzymes such as IDO2 or tryptophan 2,3-dioxygenase (TDO) [1]. In coculture systems of human allogeneic lymphocytes with dendritic cells (DCs) or tumor cells,INCB024360 inhibition of IDO1 promotes T and natural killer (NK)-cell growth, increases IFN-gamma production, and reduces conversion to regulatory T (T(reg))-like cells. IDO1 induction triggers DC apoptosis, whereas INCB024360 reverses this and increases the number of CD86 (high) DCs, potentially representing a novel mechanism by which IDO1 inhibition activates T cells [1].
in vivo: Consistent with its effects in vitro, administration of INCB024360 to tumor-bearing mice significantly inhibits tumor growth in a lymphocyte-dependent manner [1]. A single dose of INCB023843 orINCB024360 results in efficient and durable suppression of Ido1 activity in the plasma of treated mice and dogs, the former to levels seen in Ido1-deficient mice [2].
Clinical trial: A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy.


Related Products :
LRRK2-IN-1
LRRK2-IN-1
PF 04971729
PF 04971729
Price: 10mg, $295; 50mg, $795; 100mg, $1295; 200mg, $1995
GW 2580
GW 2580
Price: 50mg, $195; 100mg, $395; 200mg, $695, 1g, $1295
Cidofovir
Cidofovir
Price: 50mg, $65; 100mg, $95; 200mg, $245, 1g, $645
LY 2886721
LY 2886721
Price: 10mg, $275; 50mg, $845; 100mg, $1295; 200mg, $2295
Mdivi 1
Mdivi 1
Price: 500mg, $745; 1g, $1285
ABT333
ABT333
Price: 200mg, $945; 500mg, $1485
AGN 190299
AGN 190299
Price: 100mg, $595; 500mg, $1495;